News
Mature overall survival results of the INAVO120 trial were presented in a press conference for the American Society of ...
Pfizer is paying $1.25 billion to join the PD-(L1)xVEGF bispecific race. | Pfizer is paying $1.25 billion to join the ...
Dr. Peter McCullough testified Thursday at a Senate hearing on "The Corruption of Science and Federal Health Agencies: How Health Officials Downplayed and Hid Myocarditis and Other Adverse Events ...
The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.
How a new Trump plan could make science ‘a political football’ The NIH is already in turmoil. Billlions of dol ...
Pfizer's (NYSE: PFE) management team is confident in its 2025 opportunities. Where to invest $1,000 right now? Our analyst ...
Explore more
The U.S. has detected the NB.1.8.1 COVID-19 variant, dominant in China, through airport screenings and health departments ...
Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.
PEAPACK-GLADSTONE - Four out-of-towners were charged with trespassing after police found them at the former Pfizer ...
The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.
Preliminary data from researchers in China suggest the NB.1.8.1 variant is not better at evading the immune system compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results